blog

Study Voices 2020: Survey Findings Vol. 1

By Elizabeth Gargill on Tue, Sep 29, 2020 | 2 min read

 

During the last two weeks of August we surveyed more than 1,200 healthcare consumers, medical professionals, and members of the pharmaceutical industry for their perspectives on topics impacting today's healthcare consumer.

The findings provide a unique look at current attitudes and behaviors that inform the patient experience. They provide clinical trial sponsors with a snapshot of a critical moment in time when we're seeing the rise of telehealth, the adoption of decentralized and hybrid trials, and heightened awareness of clinical research. They also reveal new opportunities and challenges ahead for clinical trial enrollment and engagement.

Download Now

Topics: Patient Experience, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, COVID-19, Telehealth

BBK Worldwide Showcases Its Commitment to Innovation at DPharm 2020

By Aaron Fleishman on Fri, Sep 18, 2020 | 2 min read

 

DPharm. It's one of my favorite conferences that I look forward to each year. This year we will be virtual September 22-23, but still the same great energy and excitement. DPharm is a standout event that challenges and reports on innovation, with the goal of shaking up the way we conduct clinical trials so that we can reduce patient / physician burden and create greater efficiencies.

Topics: Disruptive Innovation, Conferences, Patient Experience, Study Voices, 2020 Events, Clinical Trial Innovations, COVID-19, DPHARM

Rob Laurens Discusses Navigating Patient Travel During COVID-19 with Outsourcing-Pharma

By Elizabeth Gargill on Wed, Aug 19, 2020 | 3 min read

 

Earlier this week, Principal of RSG Services Rob Laurens went one-on-one with Outsourcing-Pharma to discuss challenges associated with patient travel as COVID-19 restrictions ease.

In this in-depth interview, Rob addresses the importance of contingency planning, lessons learned, and the long-term impact of COVID-19 on patient travel. He also provides insight into services and resources that clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond. Click here to read the full article.

Topics: Patient Travel, Patient Travel Programs, RSG Arrive, COVID-19, Rob Laurens, RSG Services, Outsourcing-Pharma

Managing Patient Travel as Countries and Study Sites Reopen

By Elizabeth Gargill on Wed, Jul 29, 2020 | 2 min read

The Road to Reopening

In our newest Pharma15 Live! episode, Principal of RSG Services Rob Laurens provides guidance on managing clinical trial patient travel as COVID-19 restrictions ease and countries and study sites start to reopen.

Rob answers common questions and highlights the advantages of thoughtful pre-planning and contingency preparation. Watch now and discover strategies clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond.

 

Download the eBook

Download eBook

 

Because there's a lot to consider in terms of managing patient travel as COVID-19 restrictions ease, we've captured guidance in a special eBook to download and review at your convenience.

 

Topics: Patient Engagement, Patient Travel, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Rob Laurens

How Clinical Trial Sponsors Are Responding to COVID-19

By David Fleishman on Fri, Jul 24, 2020 | 7 min read

 

We recently sat down with BBK’s Director of Accounts David Fleishman to discuss his experience working with clinical trial sponsors during the COVID-19 outbreak. It’s clear from our conversation that many clinical trial sponsors have had to quickly pivot in response to COVID-19 and are now facing the challenge of adapting to a new normal.

 

Topics: Patient Engagement, Patient Enrollment, COVID-19, David Fleishman, Virtual

Pharma15 Live! Director’s Chair

By Aaron Fleishman on Fri, Jul 17, 2020 | 3 min read

 

As the director and one of the producers of Pharma15 Live! I wanted to share with you some insights into what we’ve learned through an amazing three seasons! First of all, if you were to tell me at the beginning of our series that it would even last three seasons, I’d tell you I’d be shocked – but nonetheless here we are and it’s been great!

Topics: Pharma15 Live!, COVID-19, Matt Kibby, Aaron Fleishman, Craig Lipset, Advarra, Season Three, Michele Russell-Einhorn, Dan Sfera, Ray Dorsey, MD

Listening to the Patient Voice Is More Important Now Than Ever Before

By BBK Worldwide on Tue, Jun 30, 2020 | 2 min read

 

As we navigate COVID-19 and beyond, understanding the patient voice is critical to overcoming clinical trial enrollment and engagement challenges. Our Study Voices infographic series sheds light on the patient voice, providing clinical trial sponsors with insight to help enhance the patient experience.

Topics: Patient Engagement, Patient Enrollment, COVID-19, Patient Voice, Infographics

The Impact of COVID-19 on Clinical Trials: Where Are We? And Where Are We Going?

By Aaron Fleishman, Director, Market Development on Tue, Jun 23, 2020 | 2 min read

As the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Ray Dorsey, MD, Matt Kibby, and Craig Lipset in this feature podcast.

Topics: Clinical Trials, Pharma15 Live!, COVID-19, Matt Kibby, Craig Lipset, Decentralized Trials, Conference Forum

How COVID-19 Is Changing Clinical Trial Patient Travel

By Mike Johnson on Thu, Jun 18, 2020 | 6 min read

 

We recently sat down with BBK’s Director of RSG Services Mike Johnson to discuss how clinical trial patient travel has been impacted by COVID-19 and how BBK's travel program RSG® Arrive has responded.

Topics: Patient Travel, RSG Arrive, COVID-19, Mike Johnson, RSG Services, Clinical Trial Patient Travel

COVID-19 Response Teaches Industry That Investing in Patient Partnership Is Key to All Research Endeavors

By Joan F. Bachenheimer, Founding Principal, CEO on Thu, May 28, 2020 | 6 min read

 

Rapid Adoption of Patient-centric Innovation Seen as Positive Outcome of COVID-19 Research Collaborations

While COVID-19 has severely affected many industries, scientific pursuit for a host of medical conditions is also threatened by sharply negative effects of the pandemic on clinical research for non-COVID-19-related pursuits. This is evidenced by an industry-reported 65 percent decline in new patient study enrollment in March 2020 relative to March 2019. The industry is adapting by borrowing from the zealous approach associated with COVID-19 research by deploying extraordinary collaboration and patient-centric services to achieve timelines for as many studies as possible.

Topics: Patient Centricity, Clinical Research, Clinical Trials, Clinical Trial Innovations, COVID-19, Joan F. Bachenheimer

 
Subscribe To Our Blog